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Abstract.  The high affinity receptor for IgE on rat 
basophilic leukemia (RBL) cells mediates antigen- 
triggered cellular degranulation.  Polyethylene glycol- 
induced membrane fusion methods were used to in- 
troduce exogenous IgE receptors into living RBL cells, 
and these were tested for normal activities.  In cell- 
cell fusion experiments,  RBL cells with fluorescein- 
labeled rat IgE bound to receptors and containing 
[5-1,2-3H(N)]hydroxytryptamine binoxalate ([3H]5HT) 
in their secretory granules were fused to cells with 
receptors occupied by rhodamine-labeled anti-dinitro- 
phenyl mouse IgE.  The fused cells showed a uniform 
surface distribution of both types of IgE,  which could 
be patched independently by anti-IgE or dinitrophen- 
ylated bovine gamma globulin (DNP~tBGG).  [3H]5HT 
release could be triggered specifically by DNP16BGG. 
In vesicle-cell fusion experiments,  plasma membrane 
vesicles, with receptors occupied by fluorescein- and 
L25I-labeled anti-DNP mouse IgE, were fused to RBL 
cells containing  [3H]5HT.  The cells showed substantial 
associated fluorescein fluorescence and  125I counts, and 
[3H]5HT release could be triggered specifically by 
DNP~tBGG.  These experiments indicate that IgE 
receptors can be dissociated from their natural cellular 
interactions and retain the ability to reassociate with 
another cell's components to deliver the transmem- 
brane signal for degranulation. 
T 
hE receptor for IgE in the plasma membrane of mast 
cells  and  basophils  mediates  antigen  triggering  of 
degranulation  in  the  allergic  response.  The  cross- 
linking  of IgE receptor complexes  initiates  the transmem- 
brane  signal,  but the mechanism  by which this  signal  is 
propagated and  leads to the  release of components  from 
secretory granules has not been elucidated (see reference 25 
for review).  One powerful approach to understanding  struc- 
ture-function relationships  in macromolecular complexes is 
purification  of essential  components and reconstitution  into 
an operational  system. Methods have been developed to pu- 
rify the receptor for IgE from the rat basophilic leukemia 
(RBL)'  cells  (18) and  for reincorporation  of the purified 
receptor  into  phospholipid  vesicles  (27). However,  func- 
tional competence of these receptors is not readily evaluated 
because the expression of activity such as degranulation  re- 
quires other parts of the cell. 
Membrane  fusion methods can  be used to  reconstitute 
complex cellular systems. For example, Schramm  first used 
polyethylene glycol (PEG) to hybridize the plasma mem- 
branes from two different cells and thereby reconstitute  the 
1. Abbreviations  used in this paper: Ceq, cell equivalents; DNP, 2,4-dinitro- 
phenyl; DNP]6BGG, dinitrophenylated bovine gamma globulin; [3H]5HT, 
[5-1,2-3H(N)]hydroxytryptamine  binoxalate;  PHA,  phytohemagglutinin; 
RBL, rat basophilic leukemia. 
components necessary for receptor-mediated adenylate  cy- 
clase activity (28).  Similar  PEG fusion methods are now 
being  applied with purified  components of this  receptor- 
coupled system to ask detailed  questions  of structure and 
function (7). In the IgE receptor system, Mazurek et al. (21) 
recently  used  Sendai  virus-mediated  fusion to  introduce 
cromolyn binding  proteins into the membranes of deficient 
RBL cells to reconstitute  degranulation  activity.  We have 
now used PEG-induced membrane fusion methods to recon- 
stitute IgE receptor complexes into RBL ceils. We have been 
able to fuse RBL cells with each other (cell-cell fusion) and 
to fuse RBL cells with plasma membrane vesicles derived 
from RBL cells (vesicle-cell fusion). In both types of experi- 
ments exogenous IgE receptors fused into RBL cells were 
able to  interact  functionally  with native  components and 
cause release from endogenous secretory granules.  This  is 
the first step toward developing a fusion reconstitution  sys- 
tem with more highly purified preparations  for studying  in 
detail  the structural  requirements  of IgE receptors in cell 
triggering. 
Materials and Methods 
lgE and Triggering  Reagents 
Mouse  monoclonal  anti-2,4-dinitrophenyl (anti-DNP)  IgE  (IgEM) was 
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82 (20) by a previously described procedure that uses affinity chromatogra- 
phy  (16). Purified rat  myeloma IgE  from tumor IR  162  (IgEa;5),  anti- 
fluorescein, and dinitrophenylated bovine gamma globulin (DNPr,  BGG) 
were gifts from Dr. Henry Metzger (National Institutes of Health). TRITC 
(Research Organics, Inc., Cleveland, OH) and FITC (Molecular Probes, 
Inc., Eugene, OR) were used to prepare fluorescent derivatives of IgE as 
previously described (9, 23).  t25Idabeled IgE was prepared by the chlor- 
amine T  method (19). Rabbit anti-IgEa (6) and anti-IgE~ (22)  were pro- 
duced and purified as previously described, and AffiniPure goat anti-rat 
IgG (H+L) was purchased from Jackson ImmunoResearch Laboratories, 
Inc., Avondale, PA. 
Cells and Plasma Membrane Vesicle Preparation 
RBL cells (subline 2H3) were maintained in stationary culture (4, 30) and 
used 5-6 d after passage. Plasma membrane vesicles were prepared from 
blebbing cells that had been treated with 50 mM (0.15% wt/vol) formalde- 
hyde and 1 mM dithiothreitol (DTT) as reported elsewhere (15), except that 
the resulting vesicles were resuspended in K buffer (135 mM KC1, 5 mM 
NaC1,  20 mM Tris-HC1,  pH 7.4)  containing 10 gg/ml butylated hydrox- 
ytoluene and dialyzed against K buffer. Vesicles prepared in PBS (150 rnM 
NaC1,  10 mM sodium phosphate, pH 7.4) caused massive cell death in fu- 
sion experiments. Vesicles prepared with this basic procedure are in a vol- 
ume of ,'ol.2 ml and have a receptor concentration of ,~20 pmol receptor/ml 
as determined from binding studies performed with t25I-labeled IgEM (15). 
The use of formaldehyde apparently does not result in a large amount of 
cross-linking in the membranes, since most of  the receptors are very mobile 
and readily redistribute upon bridging by antigen or anti-IgE, and since au- 
toradiographs of SDS-polyacrylamide gels of vesicles from cells with pre- 
bound [t25I]IgE  M  show that <10% of the label migrates as higher molecular 
weight products (15). For fusion experiments, the vesicles were saturated 
with  fluorescein- and  t~I-labeled  IgEM by  incubating  with  a  four-  to 
fivefold molar excess over receptors for 12-16 h at 4°C, collected by cen- 
trifugation at 25,000 g for 45 min, and resuspended in 200-500 Ixl K buffer. 
Membrane Fusion 
The PEG (pharmaceutical grade, Mr 1,540;  Polysciences, Inc., Warring- 
ton, PA) was melted and diluted to 60% (wt/vol) with buffered medium (Ea- 
gle's minimum essential medium with Earle's balanced salt solution contain- 
ing 20 mM Hepes, pH 7.4),  then filtered through a  0.22-1~m filter,  and 
titrated  with  NaOH  to  neutrality.  Phytohemagglutinin([PHA]  type  IV; 
Sigma Chemical Co., St. Louis, MO) was prepared in a stock solution (1 
mg/ml in PBS). For cell-cell fusion experiments, cells growing adherent in 
culture  in 75-cm  2 flasks were incubated with  15  I~Ci of [5-1,2-3H(N)] - 
hydroxytryptamine binoxalate ([3H]5HT;  New England Nuclear, Boston, 
MA). The [3H]5HT-loaded  cells were harvested by treatment for 5-15 rain 
with trypsin-EDTA (Microbiological Associates, Walkersville, MD). Tryp- 
sin activity was quenched by the addition of medium supplemented with 
10% newborn calf serum, 50 p.g/ml gentamicin, 20 mM Hepes, pH 7.4. The 
[3H]5HT-loaded ceils were centrifuged, resuspended at 2-5  ×  106 ml in 
supplemented medium and incubated 1-2 h with a 5-20-fold molar excess 
over receptors of fluorescein- (or rhodamine-) labeled IgEa at room tem- 
perature on a  l/.oto-Torque  (Cole-Parmer Instrument Co.,  Chicago,  IL). 
Cells without [3H]5HT were harvested and incubated with a 5-10 fold mo- 
lar excess of rhodamine- (or fluorescein-) labeled IgEu in the same man- 
ner. Use of fluorescein or rhodamine to label the IgEM and IgEa made no 
difference in the results. The separate cell samples were washed twice by 
centrifugation and resuspension  in buffered medium. Equal amounts of  each 
type of IgE-labeled cells (I-1.5  ×  107) were placed together in tubes, cen- 
trifuged, and resuspended in 100-150 lal of the buffered medium containing 
5 Ixg of IgER, and this mixture was subjected to the fusion procedure de- 
scribed  below.  For  vesicle-ceil  experiments,  cells  were  loaded  with 
[3H]5HT,  incubated with unlabeled IgER, and washed as described above. 
The desired volume of vesicles saturated with fluorescein- and tzSI-labeled 
IgEM was then added to the sample tubes, each containing 1-1.5  ×  107 
cells and 5  gg IgEa in 30-40  I~1 buffered medium. The  samples were 
counted for ~5I radioactivity in a 4000 gamma radiation spectrophotome- 
ter (Beckman Instruments, Inc., Palo Alto, CA) to quantify the cell equiva- 
lents (Ceq) of vesicles added in terms of the number of IgE receptors, using 
the specific activity of the [ZZSl]IgE and assuming saturation of the recep- 
tors (1 Ceq =  3  ×  105 receptors). 
For membrane fusion, samples were subjected to the following optimized 
procedure. 3-6 I.tg PHA per 107 total Ceq were added to the cell-cell or 
vesicle-ceU mixture, and the samples were mixed by gently drawing in and 
out of plastic pipette tips for 10 min. 60% PEG was added to achieve a final 
concentration of 46-50%, and the cell suspension was swirled gently for 
65 s. The samples were then diluted to 15 ml with supplemented medium 
and transferred into 75-cm  2 flasks. DNase (type III; Sigma Chemical Co.) 
was added to a final concentration of 50 gg/ml. In control samples, the same 
amount of PEG was added after the dilution. After a recovery incubation 
at room temperature for 1 h and at 37"C for 1-2 h, the cells were harvested 
from the flasks, washed twice with buffered salt solution (BSS;  135 mM 
NaCI, 5 mM KC1, 1 mM MgC12, 1.8 mM CaC12, 5.6 mM glucose, 0.1% 
gelatin, 20 mM Hepes, pH 7.4), and 5 Ixg of rat IgE were added to each 
sample. In vesicle-cell experiments, the mI was counted again to deter- 
mine the Ceq of  vesicles still associated. The cells were counted and assayed 
for  [3H]5HT  release.  Samples were observed with a  Leitz Ortholux II 
fluorescence microscope equipped with 12  (fluorescein: excitation band 
pass filter 450--490 nm, emission barrier filter 515 nm) and N2 (rhodamine: 
excitation band pass filter 530-560  nm, emission barrier filter 580 nm) 
cubes with a Leitz 50%  water immersion fluorescence objective (NA  = 
1.00). 
[JH]SHT Release Assays 
100-gl  aliquots of cells at  1-2  ×  106/ml in BSS were added to wells in a 
Falcon U-bottom microtiter plate (Becton Dickinson & Co., Oxnard, CA) 
containing serial dilutions of triggering reagent (anti-IgEa or DNP~,BGG) 
in  100 Ixl BSS or BSS containing 60%  D20.  Wells for determining total 
[3H]5HT  content contained 1%  Triton X-100, and wells for determining 
spontaneous release contained BSS without triggering reagent. The plate 
was incubated at 37°C for 1 h 15 min, harvested using a Supernatant Collec- 
tion System (Skatron Inc., Sterling, VA), and the filters were counted for 
3H-radioactivity  as  previously described (2).  The  percent of [3H]5HT 
released into the supernatants was calculated relative to the total [3H]5HT 
content. 
Results and Discussion 
The Fusion Procedure 
PEG-induced membrane fusion has been widely used as a 
means to create hybrid cells (8) and also to introduce vesicu- 
lar membranes into living cells (1, 26). The major problem 
in this approach is that conditions facilitating membrane fu- 
sion  are  severe,  leaving open  a  narrow  window  between 
efficient fusion and cytotoxicity, and this is further compli- 
cated by variability of the cells. This is a serious limitation 
in reconstitution studies which depend on a measurable ac- 
tivity of intact cells compared to, for example, PEG-induced 
production of hybridomas. In the latter case, high cell viabil- 
ity is not necessary since a new cell line can be derived from 
a single living cell. Another problem facing attempts to set 
up an experimental system for reconstituting receptors for 
IgE arises from there being no known RBL cell variant that 
lacks these receptors but contains all of  the other components 
necessary for receptor-mediated degranulation.  We could 
circumvent this problem by taking advantage of  the very tight 
binding of IgE to its receptor (Ka >  10  ~° M -~) and its slow 
dissociation rate (19). We used two types of monoclonal IgE 
(IgEM and IgEa) which could be differentially labeled with 
fluorescent probes and mI,  to monitor the distribution of 
receptors from a particular source. Also, since the two types 
of IgE have different specificities, they could be selectively 
cross-linked to trigger cellular degranulation as  a  test of 
receptor function. 
We carried out a large number of preliminary experiments 
on RBL cells to optimize conditions for causing efficient 
membrane fusion with the least amount of cytotoxicity. A 
lectin was used to cause limited membrane agglutination be- 
fore fusion (24). PHA was selected because unlike some lec- 
The Journal  of Cell Biology,  Volume 105, 1987  748 Figure 1. Fluorescence micrographs of samples containing a mix- 
ture  of  rhodanfine-IgEM-labeled  cells  and  fluorescein-IgER- 
labeled cells that had been subjected to the fusion procedure. Mi- 
croscope fields were viewed either with rhodamine (A, C, and E) 
or fluorescein (B, D, and F) optics. A and B show the same field 
which contains one fused cell exhibiting both fluorescent IgE mark- 
ers,  and two cells labeled only with fluorescein-IgER. C and D 
show the same field of a sample to which DNP~6BGG  was added. 
The field contains one fused cell and one fluorescein-IgER-labeled 
cell. E and F show a fused cell from a sample to which anti-IgEM 
was added. Bar, 5 ~tm. 
tins (13) it does not by itself cause cross-linking of cell sur- 
face IgE  and  thereby triggering  of cellular degranulation 
(data not shown). After PEG treatment, the cells were recul- 
tured for a few hours in order to select for healthy cells, since 
these adhere to plastic while the dead and dying cells do not. 
IgEM waS always bound to the exogenous source of recep- 
tors to be tested for reconstitution, and the host cells loaded 
with [3H]5HT always had IgEa bound to receptors. To mini- 
mize any replacement of the IgER bound to receptors on the 
host cells by IgEM, the presence of eXcess IgER waS main- 
rained throughout the fusion and recovery processes. 
CeU-CeU Fusion 
These experiments were carried out to determine in the gent- 
lest way possible whether receptors from the plasma mem- 
brane of one cell could communicate with granules  from 
another cell after membrane fusion. RBL cells having recep- 
tors saturated with fluorescein-labeled IgER and containing 
[3H]5HT in their secretory granules were combined under 
fusion conditions with cells having receptors saturated with 
rhodamine-labeled anti-DNP IgEM and containing no [3H]- 
5HT. Fluorescence microscopy allowed visualization of the 
fused cells. Normal RBL cells with bound, fluorescent IgE 
exhibit a ring stain of fluorescence indicating a uniform dis- 
tribution of receptors on the cell surface. When a reagent that 
cross-links IgE receptors is added to these cells, clustering 
occurs, and fluorescent patches are produced. As shown in 
Fig.  1, fused cells exhibit a ring stain and can be identified 
by the presence of  both rhodamine (Fig. 1 A) and fluorescein 
fluorescence (Fig.  1 B), Addition of DNPt6BGG to samples 
caused patching of the rhodamine-IgEM on fused cells (Fig. 
1  C),  while  the  fluorescein IgER remained  ring  stained 
(Fig.  1 D).  Addition of anti-IgEM which is cross-reactive 
for IgER caused patching of both rhodamine and fluorescein 
fluorescence on the fused cells (Fig.  1, E and F). Hence the 
IgE receptor complexes from both cells are free to diffuse 
over the fused cell plasma membrane and are clustered nor- 
mally  and  independently by  immunological cross-linking 
reagents. 
Although fluorescence microscopy reveals the degree of 
cell-cell  fusion  and  distributions  of IgEM receptor com- 
plexes on the hybridized cell, it does not allow assessment 
of  whether  those  receptors  become  functionally  recon- 
stituted with other cellular structures along the signal trans- 
duction pathway.  For this purpose IgEM-mediated degranu- 
lation  was  tested.  The  release  of  [3H]5HT  triggered  by 
DNP~6BGG  revealed the presence of IgEM receptor com- 
plexes that had become functionally linked to granules con- 
taining [3H]5HT that came from cells initially labeled only 
with  IgER. The  [3H]5HT release  from cells  triggered by 
anti-IgER  via  their  endogenous IgER  receptor complexes 
could be used as an internal measure of the cells' capacity 
to undergo receptor-mediated degranulation. 
Dose-response curves from a cell-cell fusion experiment 
are shown in Fig. 2. For comparison purposes Fig. 2 A shows 
typical curves for release triggered by DNPI6BGG and anti- 
IgER when  IgEM and  IgER are both present on the  same 
cells. The DNP~6BGG curve is broad, and maximal release 
occurs at very low doses, whereas the anti-IgER curve has 
a  narrower peak at higher doses.  For the negative control 
sample (Fig. 2 B), the same procedure was carried out as for 
the fusion sample, except that the PEG was added after dilu- 
tion of the mixed cells. As was generally observed, this con- 
trol sample shows  some apparent DNP16BGG-triggered re- 
lease above background, which is probably due mostly to a 
small amount of exchange of the IgEM and IgER (as shown 
in  a  vesicle-cell experiment below).  Also,  there  may be 
some uptake of [(3H)5HT] by the IgEM-labeled  cells occur- 
ring during the recovery incubations after the fusion.  The 
DNP~6BGG-triggered  release  of  the  sample  containing 
fused cells (Fig. 2 C) is considerably above that of the con- 
trol, and the dose-response curve has the same shape as for 
normal cells (Fig. 2 A). 
A large number of cell-cell fusion experiments were car- 
ried out,  and the various  samples  were evaluated by two- 
color fluorescence microscopy and by the degranulation as- 
say. Occasionally the experiments did not work: most of the 
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Figure 2. [3H]5HT release from cells triggered by DNPI6BGG (e) or anti-IgER (o). Dose-response curves of (A) a sample of cells labeled 
with both IgER and anti-DNP IgEM; (B) the control sample from a cell-cell fusion experiment;  and (C) the fusion sample of the same 
experiment.  For ceil-cell fusion experiments,  IgER-labeled ceils that had been loaded with [3H]5HT were mixed with anti-DNP IgEM- 
labeled cells and treated as described  in Materials and Methods.  The error bars represent the range of duplicate samples. Dashed lines 
indicate spontaneous release (duplicate samples). 
ceils died and/or little or no fusion was observable. There 
was no obvious explanation for these failures other than the 
variability of the cells in their reaction to the same treatment. 
However, we never observed false positive results; i.e., there 
was always the same or more [3H]5HT release stimulated 
by DNPI6BGG in  the  fusion  samples than  in the  control 
samples.  Four  representative cell-cell  fusion  experiments 
with positive results are summarized in Table I. The control 
samples contained either cells saturated with IgEM or IgErt 
that had been subjected to the fusion procedure separately 
before mixing the suspensions (Exp. 1) or the combined cells 
to which the same amount of PEG was added after dilution 
(Exps. 2-4). Cell viability in the final fusion and control sam- 
pies was always 90 % or greater by trypan blue exclusion, and 
recovery of cells  from the  initial  mixtures was  generally 
30-50% (not corrected for fusion of cells in those samples). 
The percentage of fused cells was calculated by counting 
rhodamine-labeled cells and the number of those that also 
exhibited fluorescein fluorescence. This varied from 5-19 % 
in fusion samples and was always ~<1% in the control sam- 
pies. To put some perspective on these values the following 
may be considered. If all of the cells in the fusion samples 
fused statistically in pairs (1 XX: 2 XY: 1 YY), the observed 
number of fluorescein- and rhodamine-labeled cells would 
be 66 % of the rhodamine-labeled cells. Using this model, we 
obtained hybridization efficiencies of 7.5-29 %. This may be 
an underestimation  because large aggregates of ceils  (not 
scored) probably included a higher percentage of fused cells, 
and also fusion of three or more cells was occasionally ob- 
served.  These  fusion  efficiencies  compare to  the  <0.01% 
typically obtained with standard procedures for making hy- 
bridomas (14). 
For  a  quantitative  measure  of the  apparent  functional 
reconstitution  of receptors in  the degranulation  assay,  the 
[3H]5HT  release  stimulated  by  exogenous  receptors  (la- 
beled with anti-DNP IgEM) was compared to the [3H]5HT 
release stimulated by the endogenous receptors (labeled with 
IgER).  The relative DNP16BGG  release was calculated for 
each  sample:  (net  DNP~6BGG  release/net  anti-IgER  re- 
lease), where the net triggered release values used were ob- 
tained by subtracting the spontaneous release from the max- 
ima of the respective dose-response curves (see Fig. 2). As 
shown in Table I, the relative DNPI6BGG release in fusion 
samples was 0.2-0.4 over that in control samples in success- 
ful  cell-cell  fusion  experiments.  Considering  the  same 
model as above, if all of the combined cells fused statistically 
in pairs and if DNP~6BGG  and anti-IgER were inherently 
Table L  Cell-Cell Fusion* 
% [3HI5HT Release§ 
Percent  Net DNPt6BGG/ 
Exp.  PEG  PHA  fused:~  Net DNP16BGG  net anti-IgER 
1  +(f.s.)ll  +  0  3.0  0.12 
+  --  1  3.9  0.14 
+  +  9  10.3  0.42 
2~  a.d.  +  1  1.7  0.17 
+  -  1  3.1  0.37 
+  +  10  4.4  0.46 
+  +  5  5.9  0.61 
3  a.d.  +  0  3.1  0.13 
+  -  2  2.7  0.15 
+  +  8  7.1  0.32 
+  +  19  8.4  0.40 
4**  a.d.  +  0  7.2  0.23 
+  +  10  9.4  0.53 
+  +  16  9.4  0.55 
* Samples were treated with 3-5 lag PHA/107 cells (+) or not (-) and 50% 
PEG (+) or the same amount of PEG was added after dilution (a.d.). 
$ Number of double-labeled cells per 100 rhodamine-labeled cells. 
§ [3H]5HT  release  assays  were  performed  as  described  in  Materials and 
Methods. Spontaneous  release values of samples  with PEG added after dilution 
were 19.9  +  10.9%.  Spontaneous  release values of fusion samples were 20.9 
+  8.45%. 
PI f.s., fused separately. Separate  samples of IgEu and IgER-labeled cells were 
subjected to PHA and PEG, diluted, and then mixed together for the remaining 
procedures. 
¶ In this experiment tfuorescein-IgER was used and the anti-IgER trigger was 
anti-fluorescein. 
** In this experiment the  [3H]5HT release assays were performed in 30% 
D20. 
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DNP~6BGG would be expected to be 0.5.  Although this is a 
highly  oversimplified view,  it  does  suggest  that  the  (net 
DNP~6BGG release/net anti-IgER release) shown by the fu- 
sion  samples  over that  of the  control  samples  reflects  a 
significant  reconstitution  of exogenous receptors  that  are 
functional. In this regard it should be noted that under nor- 
mal  conditions ~<10% of a  single cell's receptors need be 
involved in triggering maximal degranulation (11). Conse- 
quently,  the percentage of the  exogenous receptors intro- 
duced by cell fusion that have been functionally integrated 
cannot be estimated accurately. 
Other observations made in the cell-cell fusion studies are 
exemplified by  the  experiments  shown  in  Table  I.  Even 
within the same experiment there was some variability in the 
success of fusion in two separate samples treated essentially 
the same (last two lines of Exps.  2--4).  Cells subjected to 
50% PEG and no PHA sometimes showed evidence of fu- 
sion, but addition of lectin generally provided a substantial 
enhancement (Exp. 2). We tested the use of D20 in the de- 
granulation assay (in Exp. 4) since this is known to enhance 
the release caused by a low level of stimulation (12). In these 
experiments D20 generally had no preferential effect on the 
fusion samples and usually caused a relative increase in re- 
lease of the control sample, suggesting that release triggered 
by the small amount of exchanged IgEra is amplified in the 
presence of this reagent. 
In spite of the variation of fusion efficiency among experi- 
ments, our results provide strong evidence that IgE receptors 
from one cell can become structurally and functionally in- 
tegrated into another cell after the two have been fused. (a) 
At the detection limit of fluorescence microscopy all recep- 
tors from each cell diffuse over the combined plasma mem- 
brane and can be cross-linked to form patches on the cell sur- 
face. (b) At least some significant percentage of these surface 
receptors can cross-interact with intracellular components of 
the mated cell to trigger release of its granular contents. An 
important extension of these studies will be to determine if 
cross-triggering can occur between heterologous cell types. 
For example it would be interesting to see if IgE receptors 
from RBL cells can cause degranulation of neutrophils after 
the two types of cells have been fused. 
Figure 3. Fluorescence micrographs from a vesicle-cell fusion ex- 
periment in which fluorescein-IgEM  was bound to vesicles and un- 
labeled IgEs was bound to cells. A is the fusion sample and B is 
the control sample. Fluorescein optics were used, and the photo- 
graphic procedures were identical for the fusion and control sam- 
ples. Bar, 5 p.m. 
Vesicle-CeU Fusion 
These experiments were undertaken to determine whether 
receptors removed from intact cells in the form of plasma 
membrane vesicles retain their ability to interact with other 
cellular components after reconstitution to trigger degranu- 
lation. Plasma membrane vesicles were prepared from RBL 
cells,  and their IgE receptors were saturated with fluores- 
cein- and 125I-labeled IgEM. These were combined with in- 
tact cells having receptors saturated with IgER and contain- 
ing  [3H]5HT in  their secretory granules.  In  samples  that 
had been treated with lectin and PEG under fusion condi- 
tions,  easily visible fluorescein fluorescence was found to 
be associated with all of the RBL cells (Fig. 3 A). Much of 
the fluorescence appeared in clumps which probably repre- 
sented vesicles that had agglutinated with the cells by means 
of the lectin. There were also smooth areas of uniform stain 
on the cell surface, and these appeared to be areas where the 
vesicles had become integrated with the cell by membrane 
fusion.  Control samples included approximately the same 
amounts of cells and vesicles and were treated the same way, 
except that the PEG was added after dilution. These showed 
a much smaller amount of fluorescence that all appeared as 
clumps (Fig. 3 B). 
Functional reconstitution of the receptors originating in 
the plasma membrane vesicles was tested with the degranula- 
tion assay,  and positive results were observed in many ex- 
periments.  The  dose-response  curves  of one  of these  is 
shown in Fig. 4. As with the cell-cell fusion some release 
is triggered by DNP16BGG in the control sample (Fig. 4 A), 
but this is considerably less than in the fusion sample (Fig. 
4 B). The vesicle-cell fusion experiments failed more often 
than the cell-cell fusion experiments, and this was attributed 
mostly to a higher level of cytotoxicity under the conditions 
required for fusion. In these experiments there was always 
more fluorescent and L~-5I-labeled  vesicle material associated 
with the cells in the fusion sample than in the control sample, 
but DNP~6BGG-triggered [3H]5HT release was not always 
significantly greater in the fusion sample. In no experiment 
did we observe significantly more DNP16BGG-triggered re- 
lease in the control sample. In the case of vesicle-cell fusion 
we found that degranulation assays carried out in the pres- 
ence of 30% D20 showed positive results more often, sug- 
gesting that the low level stimulation by exogenous receptors 
was enhanced by this reagent. 
The results of three vesicle-cell experiments with positive 
results are shown in Table II.  Cell viability was >85%  by 
trypan blue exclusion for both fusion and control samples at 
the final stage.  However, cell recovery was typically lower 
in  the  fusion  samples  (30-60%)  than  in  control  samples 
(50-75%).  The amount of cell equivalents of vesicles as- 
sociated with the cells before and after the fusion procedure 
was quantified by the bound [125I]IgEM. The fusion samples 
had 0.1-0.4 Ceq of vesicles associated per cell after the final 
wash, which was 24-34 % of the amount added initially and 
3-4 times the amount associated with cells in the control 
samples in the same experiment. For the fusion samples (net 
DNP16BGG release/net anti-IgER  release) was 0.1-0.4 over 
that of control samples, showing functional reconstitution of 
exogenous receptors. Exchange of IgEM for IgER on the en- 
dogenous cellular receptors was probably the main reason 
for DNPI6BGG release in the control samples. This is indi- 
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Figure  4.  [3H]5HT release  from cells 
triggered by DNP~6BGG (e) and anti- 
IgER (O) from a vesicle-cell fusion ex- 
periment. Dose-response curves of (,4) 
the control sample and (B) the fusion 
sample. For vesicle-cell fusion experi- 
ments, IgER-labeled cells that had been 
loaded with [3H]5HT were mixed with 
anti-DNP  IgEM-labeled vesicles  and 
treated  as  described  in  Materials  and 
Methods. The error bars represent the 
range of  duplicate samples. Dashed lines 
indicate spontaneous release (duplicate 
samples). 
cated by Exp. 2 of Table II, in which the addition of excess 
IgER after the fusion procedure was  omitted,  resulting in 
high release in the control samples containing no PHA or no 
PEG.  Although the greater number of vesicles associated 
with the cells in fusion samples by the combination of PHA 
and 50%  PEG might possibly result in enhanced IgE ex- 
change, we feel this is very unlikely on the basis of three ob- 
servations (data not shown). (a) PHA-mediated agglutination 
of  vesicles to cells persists in both fusion and control samples 
until trypsin treatment of cells after the recovery incubation. 
(b) A sample containing the same amount of vesicles but no 
PHA or PEG shows nearly identical degranulation in re- 
sponse to DNP~6BGG as the control sample with PHA and 
3.5% PEG, and this is less than the response of the fusion 
sample. (c) IgE-receptor dissociation is not enhanced under 
the conditions of the fusion procedure with 50 % PEG. 
Positive results from the vesicle-cell fusion experiments 
indicate that some portion of the receptors contained in the 
isolated plasma membranes retain their ability to mediate the 
signal for degranulation after they have been reconstituted 
with  intact  cells.  We  would  expect  (net  DNPt6BGG  re- 
lease/net anti-IgER)  =  1 with successful introduction of 0.1 
Ceq of competent receptors per cell (11; assuming release 
triggered by anti-IgER and DNPInBGG is equal). The spe- 
cific relative DNP~6BGG release of 0.44 seen in Table II, 
Exp. 1 (0.59 minus 0.15) corresponds to functional reconsti- 
tution of 0.03-0.10 Ceq of receptors per cell if the occupancy 
data of Fewtrell (11) are used as a reference. These rough cal- 
culations indicate that a significant fraction of the exogenous 
receptors associated with the cells after the fusion procedure 
have been functionally reconstituted. Since there is evidence 
that serine esterases are involved in the signal transduction 
process (17) we generally did not use protease inhibitors in 
preparing the vesicles, and proteolysis is one way in which 
the exogenous receptors could be rendered inactive.  Poly- 
acrylamide gels of IgE receptors immunoprecipitated from 
solubilized  vesicles  showed  intact  (1,  13,  and  y  receptor 
subunits (not shown), but we cannot rule out that some por- 
tion of the receptors or some other critical protein may have 
been digested. Vesicles prepared in the presence of protease 
inhibitors  did  not  yield  more  positive  results  (data  not 
shown). 
The vesicles used in the vesicle-cell fusion experiments 
are prepared by causing the cellular plasma membrane to 
bleb (15), and they have been shown to lack an intact cyto- 
skeleton (3, 29). Since there is strong evidence that clustered 
IgE receptors become associated with the cytoskeleton and 
that this event is correlated with the signal for degranulation 
in normal RBL cells (23), it is possible that some continuing 
interactions with the cytoskeleton are important for main- 
taming  receptor activity.  Therefore we  also  tried plasma 
membrane vesicles prepared by nitrogen cavitation (10) in 
several fusion experiments. We obtained positive results in 
some of these experiments (data not shown), but functional 
reconstitution of exogenous receptors delivered to the cell in 
this type of vesicle as measured by the degranulation assay 
was not better than that observed with the blebbed membrane 
Table II.  Vesicle-Cell Fusion* 
[3H]5HT Release§ 
Ceq$ 
attached/  Net DNP~6BGG/ 
Exp.  PEG  cell  Net DNPt6BGG  net anti-IgER 
%  % 
1  a.d.  0.026  (7.6)  3.4  0.15 
+  0.096  (24)  15.3  0.59 
211  a.d.  0.0  (0)I  1.3  0.02 
+  0.045  (7.1)**  30  0.46 
a.d.  0.036  (7.5)  31  0.47 
+  0.15  (33)  40  0.61 
3¢$  a.d.  ND§~  3.7  0.12 
+  ND  9.6  0.29 
* Fusion  samples were treated with 2.3--4.9  ~tg PHA/107 cells and 46-50% 
PEG (+). Control  samples included PHA and had the same amount of PEG 
added after dilution (a.d.). 
$ Ceq  of IgE associated  with the  cells  after  the  final washing.  Numbers in 
parentheses  indicate the percentage of Ceq of vesicles added initially to the 
cells that remained associated after the final washing. 
§ [3H]5HT release  assays  were  performed  as  described  in  Materials  and 
Methods. Spontaneous release values of samples with PEG added after dilution 
were 8.9  5:  1.4%. Spontaneous release values of fusion samples were 10.8 + 
0.8%. 
11 Excess IgEs was not added to the samples in this experiment. 
¶ No vesicles were included in this sample. 
** No PHA was added to this sample. 
$~ In this  experiment,  the  [3H]5HT release  assays  were performed  in 30% 
D20. 
§§ ND, not determined.  [~25I]IgE  was not used in this experiment. 
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ations are important  they  can reform. 
We have shown that IgE receptors can maintain their abil- 
ity to mediate signal transduction  during transfer between the 
plasma membranes of two different RBL cells. An important 
use  of this  reconstitution  approach  will be  to modify  the 
receptor in a specific manner and assess the affect on func- 
tion. For example, we have recently shown that the cytoplas- 
mically exposed portions of the receptor can be cleaved pro- 
teolytically  from inside-out plasma membrane vesicles  or 
from solubilized vesicles  (Hammes,  S.,  D.  Holowka,  and 
B.  Baird,  manuscript  submitted  for  publication),  and  a 
reconstitution experiment should show whether these por- 
tions are important  for signal transduction.  As a first step to 
this experiment we have  had some success  in solubilizing 
plasma membrane vesicles,  reforming them by removal of 
detergent, and fusing them with intact cells (data not shown). 
Although  realizing  the  full  potential  of  the  vesicle-cell 
reconstitution method will require that the fusion efficiency 
be improved, this approach looks promising as a way to study 
structure-function  relationships  in  more  detail.  It  should 
eventually be possible to reconstitute purified, modified IgE 
receptors in reformed vesicles or synthetic lipid vesicles (27) 
and then into intact cells using methods similar to those de- 
scribed here. 
Katherine Estes and Laura L. Monfalcone are National Institutes  of Health 
Predoctoral  Trainees and were supported by grant  GM07273. 
This work was supported by National Institutes  of Health grant A18306. 
Received for publication 7 January  1987, and in revised form 23 April 1987. 
References 
1. Baird, B., and P. Heukart. 1983. Enhancement of the recognition by cyto- 
toxic T lymphocytes  (CTL) of  target membrane  antigens after fusion with 
whole cells. Cell. Immunol.  75:312-327. 
2.  Baird, B., D. Sajewski, and S. J. Mazlin.  1983.  A microtiter plate assay 
using cellulose acetate filters  for measuring cellular [3H]serotonin  re- 
lease. J.  Immunol.  Methods.  64:365-375. 
3. Barak, L. S., and W. W. Webb. 1982. Diffusion of low density lipoprotein- 
receptor complex on human fibroblasts. J.  Cell Biol. 95:846-852. 
4. Barsumian, E. L., C. Isersky, M. G. Petrino, andR. P. Siraganian. 1981, 
IgE-induced histamine release from rat basophilic leukemia cell  lines: 
isolation  of  releasing  and  non-releasing  clones.  Eur.  J.  Immunol. 
11:317-323. 
5. Bazin, H., P. Querijean, A. Beckers, J. F. Heremans, and F. Dessy. 1974. 
Transplantable immunoglobulin-secreting  tumors in rats. IV. Sixty-three 
IgE-secreting immunocytoma tumors. Immunology.  26:713-723. 
6. Carson, D. A., and H. Metzger. 1974. Interaction oflgE with rat basophilic 
leukemia cells. IV. Antibody-induced redistribution of IgE receptors. J. 
lmmunol.  113:1271-1277. 
7. Cerione, R. A., J. L. Benovic, J. Codina, L. Birnbaumer, R. J. Lefkowitz, 
and M. G. Caron. 1986. The 13-adrenergic receptor coupled adenylate cy- 
clase: reconstitution of the functional interactions of the various purified 
components. In The Receptors. Vol.  4. P. M. Conn, editor,  Academic 
Press Inc., Orlando, FL.  1-36. 
8. Davidson, R. L., and P. S. Gerald.  1976. Improved techniques for the in- 
duction of mammalian  cell hybridization by polyethylene glycol. Methods 
Cell BioL  15:325-338. 
9. Erickson, J.,  P. Kane, B. Goldstein, D.  Holowka,  and B. Baird.  1986. 
Cross-linking of IgE-receptor complexes at the cell surface: a fluores- 
cence method for studying the binding of monovalent and bivalent hap- 
tens to IgE. Mol. lmmunol.  23:769-781. 
10. Ferber, E., K. Resch, D. F. H. Wallach, andW. lmm. 1972. Isolation and 
characterization of lymphocyte plasma membranes. Biochim.  Biophys. 
Acta.  266:494-504. 
11. Fewtrell, C.  1984. Activation and desensitization of receptors for IgE on 
tumor basophils. In  Calcium in Biological  Systems. R.  P.  Rubin, G. 
Weiss,  and  J.  Putney,  Jr.,  editors.  Plenum Publishing Corp.,  NY. 
129-136. 
12. Fewtrell, C., and H.  Metzger.  1980.  Larger oligomers of IgE are more 
effective than dimers in stimulating rat basophilic leukemia cells. J. Im- 
munol.  125:701-710. 
13. Fewtrell, C., A. Kessler, and H. Metzger.  1979. Comparative aspects of 
secretion from tumor and normal mast cells. Adv.  Inflammation Res. 
1:205-211. 
14. Goding, J.  1983. In Monoclonal Antibodies: Principles and Practice. Aca- 
demic Press Inc., New York, NY. 70. 
15. Holowka,  D., and B. Baird.  1983.  Structural  studies on the membrane- 
bound immunoglobulin E-receptor complex. I. Characterization of large 
plasma membrane vesicles from rat basophilic leukemia cells and inser- 
tion of amphipathic fluorescent probes. Biochemistry.  22:3466-3474. 
16. Ho!owka, D., and H. Metzger. 1982. Further characterization of the beta 
component of the receptor for IgE. Mol. lmmunol.  19:219-227. 
17. Ishizaka, T., and K. Ishizaka. 1984. Activation of mast cells for mediator 
release through IgE receptors. Prog. Allergy.  34:188-325. 
18. Kanellopoulos, J., G. Rossi, and H. Metzger. 1979. Preparative isolation 
of the cell receptor for immunoglobulin E. J.  BioL  Chem. 254:7691- 
7697. 
19. Kulczycki, A., Jr,, and H. Metzger. 1974. The interaction oflgE with rat 
basophilic leukemia cells. II. Quantitative aspects of the binding reaction. 
J.  Exp. Med. 140:1676-1695. 
20. Liu, F.-T., J. W. Bohn, E. L. Ferry, H. Yamamoto, C. A. Molinaro, L. A. 
Sherman, N. R. Klinman, and D. H. Katz.  1980.  Monoclonal dinitro- 
phenyl-specific murine IgE antibody: preparation, isolation, and charac- 
terization. J.  Immunol. 124:2728-2736. 
21. Mazurek, N., P. Bashkin, A. Loyter, and I. Pecht.  1983.  Restoration of 
Ca  2÷ influx and degranulation capacity of variant RBL-2H3 cells upon 
implantation of isolated cromolyn binding protein. Proc, Natl. Acod. Sci. 
USA. 80:6014-6018. 
22. Menon, A. K., D. Holowka, and B. Baird.  1984. Small oligomers ofimmu- 
noglobulin E (IgE)  cause large-scale clustering of IgE receptors on the 
surface of rat basophilic leukemia cells. J.  Cell Biol. 98:577-583. 
23. Menon, A. K., D. Holowka, W. W. Webb, andB. Baird. 1986. Clustering, 
mobility, and triggering activity  of small oligomers of immunoglobulin 
E on rat basophilic leukemia cells. J.  Cell Biol. 102:534-540. 
24. Mercer, W. E., and R. A. Schlegel.  1979.  Phytohemagglutinin enhance- 
ment of cell fusion reduces polyethylene glycol cytotoxicity. Exp. Cell 
Res.  120:417-421. 
25. Metzger, H., G. Alcarez, R. Hohman, J.-P.  Kinet, V. Pribluda, and R. 
Quarto.  1986.  The receptor with high affinity  for immunoglobulin E. 
Annu.  Rev. lmmunol.  4:419-470. 
26. Poste, G., and G. L. Nicolson. 1983. Arrest and metastasis of blood-borne 
tumor cells are modified by fusion of plasma membrane vesicles from 
highly metastatic cells. Proc. Natl. Acad. Sci. USA. 77:399-403. 
27. Rivnay, B., G. Rossi, P. Heukart, and H. Metzger.  1984. Reconstitution 
of the receptor for immunoglobulin E  into liposomes. J.  Biol. Chem. 
259:1212-1217. 
28. Schramm, M.  1979. Transfer of glucagon receptor from liver membranes 
to a foreign adenylate cyclase by a membrane fusion procedure. Proc. 
Natl. Acad. Sci. USA. 76:1174-1178. 
29. Tank, D. W.,  E.-S. Wu, and W. W. Webb.  1982.  Enhanced molecular 
diffusibility  in muscle membrane blebs:  release of lateral  constraints. J. 
Cell Biol. 92:207-212. 
30. Tanrog, J. D., C. Fewtrell, and E. Becker.  1979. IgE mediated triggering 
of rat basophil leukemia cells: lack of evidence for serine esterase activa- 
tion. J.  lmmunol.  122:2150-2153. 
Estes et al. Reconstitution of lgE Receptor  Complexes  753 